Free U.S. shipping $175+

Cartalax — Novaryn Research
Hover to zoom
Anti-Aging & LongevitySynthetic research compound

Cartalax

$119.99
20 mg

Cartalax is a short synthetic peptide from the Khavinson bioregulator series, a group of tri- and tetrapeptides investigated for tissue-associated effects on gene expression.

It appears in laboratory research on connective-tissue cell models, where investigators examine whether short peptide sequences influence transcriptional activity in cultured cells.

Research areas
Peptide bioregulator studiesConnective-tissue cell modelsGene-expression researchPreclinical research
Form: Lyophilized (freeze-dried)
Compound class
Synthetic research compound
Research category
Anti-Aging & Longevity
SKU
NVR-CARTALAX-20MG
Appearance
Lyophilized powder
Storage
Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
20 mg$119.99$6.00/mg
1
$119.99per 20 mg$6.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know

More detail on Cartalax.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound
The bioregulator literature proposes that very short peptides can interact with DNA or chromatin-associated proteins to influence transcription in a tissue-associated manner. That hypothesis has generated a body of published work, largely from a small number of research groups, and independent replication remains limited. Cartalax is studied within that framework in cartilage- and connective-tissue-derived cell cultures. Investigators using it should treat available findings as preliminary and design experiments with well-characterized comparators. Research use only.
Peptide class
Synthetic research compound
Mechanism (research context)
Extended mechanistic characterization for this compound is available in the published literature. Consult peer-reviewed references for detailed pathway analysis.
Why it is studied
Cartalax is studied within its research category (Anti-Aging & Longevity) as a defined-sequence reference compound for laboratory investigation.
Current areas of research
Peptide bioregulator studiesConnective-tissue cell modelsGene-expression researchPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

Cartalax is supplied for in vitro laboratory research. Batch-specific analytical documentation is provided when available for the released lot.

Related

Related research materials

View all →
Cartalax
20 mg · $119.99
Notify me when available